Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia

BACKGROUND: A rapid increase in circulating vaccine-derived poliovirus type 2 outbreaks, and the need to reserve inactivated poliovirus vaccine (IPV) for routine immunisation, has increased the value of fractional dose IPV (fIPV) as a measure to prevent acute flaccid paralysis. However, the intrader...

Descripción completa

Detalles Bibliográficos
Autores principales: Bashorun, Adedapo O, Badjie Hydara, Mariama, Adigweme, Ikechukwu, Umesi, Ama, Danso, Baba, Johnson, Njilan, Sambou, Ngally Aboubacarr, Fofana, Sidat, Kanu, Francis J, Jeyaseelan, Visalakshi, Verma, Harish, Weldon, William C, Oberste, M Steven, Sutter, Roland W, Jeffries, David, Wathuo, Miriam, Mach, Ondrej, Clarke, Ed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786671/
https://www.ncbi.nlm.nih.gov/pubmed/34951974
http://dx.doi.org/10.1016/S2214-109X(21)00497-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786671/
https://www.ncbi.nlm.nih.gov/pubmed/34951974
http://dx.doi.org/10.1016/S2214-109X(21)00497-6

Ejemplares similares